LY294002 hydrochloride is a selective, cell-permeable inhibitor of PI3K that blocks autophagosome formation and is used in research related to cancer and oncology; it inhibits tumor growth and induces apoptosis in vivo, particularly in LoVo tumors and murine models of carcinomatous peritonitis; it significantly suppresses ovarian cancer growth and ascites formation; in vitro, it inactivates Akt/PKB, inhibits cell proliferation, induces apoptosis, causes nuclear condensation, reduces cytoplasmic volume, and arrests the cell cycle at the G1 phase, thereby potently inhibiting the proliferation of melanoma and osteosarcoma (MG-63) cells; its effects on the cell cycle are utilized to study the relationship between PI3K signaling pathways and cancer cell cycle regulation.